Bioinformatics and experimental insights into F2RL1 as a key biomarker in cervical cancer diagnosis and prognosis
- Yonggang Dai 1,2, Chunxiang Li 3, Shiliang Cheng 1, Hongya Wang 1, Xuewei Zhuang 4
- Yonggang Dai 1,2, Chunxiang Li 3, Shiliang Cheng 1
- 1Department of Clinical Laboratoryaboratory, Shandong Provincial Third Hospital, Shandong University, No.11 Middle Wuyingshan Road, Tianqiao, Jinan, 250031, Shandong, China.
- 2College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
- 3Department of Clinical Microbiology Laboratory, Shandong Second Provincial General Hospital, Jinan, Shandong, China.
- 4Department of Clinical Laboratoryaboratory, Shandong Provincial Third Hospital, Shandong University, No.11 Middle Wuyingshan Road, Tianqiao, Jinan, 250031, Shandong, China. zhuangxuewei@sdu.edu.cn.
- 0Department of Clinical Laboratoryaboratory, Shandong Provincial Third Hospital, Shandong University, No.11 Middle Wuyingshan Road, Tianqiao, Jinan, 250031, Shandong, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.F2RL1 is highly expressed in cervical cancer (CCa) tissues and is linked to poorer survival. This study reveals F2RL1 as a potential biomarker for early CCa diagnosis and prognosis, impacting immune cell infiltration.
Area Of Science
- Oncology
- Molecular Biology
- Immunology
Background
- Cervical cancer (CCa) is a major global health issue with incompletely understood molecular mechanisms.
- F2RL1, a gene implicated in various cancers, has an unclear role in CCa pathogenesis.
Purpose Of The Study
- To investigate the expression, diagnostic, and prognostic significance of F2RL1 in cervical cancer.
- To explore the relationship between F2RL1 and immune infiltration in CCa.
Main Methods
- Utilized TCGA database for differential gene expression analysis (Limma) and survival analysis.
- Performed ROC analysis, immune-related gene identification (ImmPort), and functional enrichment (GO, KEGG, GSEA).
- Validated F2RL1 expression in patient samples (HPV, TCT, qPCR, WB, ELISA).
Main Results
- F2RL1 expression is significantly elevated in CCa tissues compared to normal tissues.
- High F2RL1 expression correlates with reduced Overall Survival (OS), Progression Free Interval (PFI), and Progression Free Survival (PFS).
- F2RL1 demonstrated high diagnostic accuracy (AUC=0.996) and was linked to immune cell infiltration, particularly TFH and cytotoxic cells, suggesting immune evasion.
Conclusions
- F2RL1 is a promising biomarker for the early diagnosis and prognosis of cervical cancer.
- F2RL1 expression is associated with CCa progression and immune evasion mechanisms.
- Elevated F2RL1 in exfoliated cells and serum supports its potential for non-invasive detection.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

